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Nasal cytology is a very useful diagnostic tool in nasal disorders, being able to detect both the cellular
modifications of the nasal epithelium caused by either allergen exposure or irritative stimuli (that may be physical
or chemical, acute or chronic), or inflammation. Over these past few years, nasal cytology has allowed to identify
new disorders, such as the non-allergic rhinitis with eosinophils (NARES), the non-allergic rhinitis with mast cells
(NARMA), the non-allergic rhinitis with neutrophils (NARNE), and the non-allergic rhinitis with eosinophils and mast
cells (NARESMA). The rhinocytogram is actually able to distinguish the different forms of allergic rhinitis and to
suggest the appropriate treatment, such as antinflammatory drugs or allergen immunotherapy. The technique is
easy to perform and nasal cytology is therefore particularly suitable even for children. Such a consideration
suggests the utility of a systematic use of nasal cytology in the diagnostic work-up of nasal disorders in children, in
order to reach a proper defined diagnosis and to set a rational therapeutic approach: in facts, these two elements
are fundamental in order to prevent from complications and to improve the patient’s quality of life.
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Nasal cytology is a very useful diagnostic tool in diagno-
sing nasal allergic disorders [1,2]. The technique allows
clinicians to detect the cellular modifications of the nasal
epithelium caused by exposure to either physical or
chemical [3,4], acute or chronic irritations. Also, it makes
it easy to evaluate the different types of inflammation
(viral, bacterial, fungal or parasitical) [5,6]. Over the
past few years, nasal cytology has shown to be quite
an attractive tool in clinical and scientific applications.
Indeed, a large number of papers has been published
on the cytological characterization of nasal pathologies,
and particularly on allergic and non allergic rhinitis.
These researches contributed to the understanding of
some pathophysiological mechanisms of allergic rhi-
nitis, and to the identification of new disorders, namely
the non-allergic rhinitis with eosinophils (NARES), the
non-allergic rhinitis with mast cells (NARMA), the non-
allergic rhinitis with neutrophils (NARNE), and the
non-allergic rhinitis with eosinophils and mast cells
(NARESMA) [7-9].* Correspondence: gl.marseglia@smatteo.pv.it
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The nasal mucosa is formed by a ciliated pseudo-
stratified epithelium (Figure 1), which is composed of
ciliated mucous-secreting cells, striated and basal. The
ciliated cell (Figure 2) is the most differentiated element
of the nasal mucosa [10] and, together with mucous-
secreting cells, it represents the first-line defence located
in the airways (the so-called mucus-ciliated system). The
diagnosis of nasal disorders through nasal cytology is
based on the consideration that, in healthy subjects, the
nasal mucosa is composed of four normal subsets of
cells, which commonly characterize the pseudo-stratified
epithelium; besides neutrophils, no other cells are
detected in healthy individuals (Figure 3). Therefore, on a
rhinocytogram, the presence of eosinophils, mast cells,
bacteria, spores and fungi has to be considered as a clear
sign of nasal pathology.
Nasal cytology was introduced in 1889, when Gollash
highlighted the presence of numerous eosinophils in the
nasal secretions of an asthmatic patient and suggested
that these cells could be the key elements for the patho-
genesis of the disease [11]. Eyermann, in 1927, detected
the presence of granulocyte eosinophils in the nasal secre-
tions of allergic patients and showed their importance inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Nasal Mucosa: the ciliated pseudo-stratified epithelium, composed of ciliated mucous-secreting cells (striated and basal).
Staining MGG 400X.
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a great value was attributed to the identification of spe-
cific cellular subsets related to different nasal pathologies
[13-15], and this consideration opened the way to the
routine use of nasal cytology in the study of allergic and
non allergic, infectious and inflammatory rhinitis. Differ-
ent factors have been responsible for the increased inter-
est for this diagnostic tool and its widespread use: on oneFigure 2 Nasal Mucosa: the ciliated cell, part of the mucus-
ciliated system, representing an important defence localized in
the airways. Staining MGG 2000X.hand, the fact that the technique is easy to perform, and,
on the other hand, that it is a non-invasive approach.
Therefore, this tool may be easily repeated on the same
patient, with is essential both in the follow-up of the dis-
ease and to monitor the efficacy of medical and surgical
interventions. Based on the fact that this method is
simple, safe, non-invasive and poorly expensive, it could
be routinely used in outpatient clinics at all ages, even
in children [16].
The following steps characterize the cytological tech-
nique: sampling, processing (with fixing and staining),
and observation through microscopy. The cytological
sampling consists of collecting the nasal mucosa surface
cells and it can be performed either through the use of a
sterile swab (such as an oro-pharyngeal swab) or a small
scraper made of disposable plastic such as the Rhino-
probe (Arlington Scientific, Springville, UT, USA) [17].
Sampling collection may be even done by scraping the
middle portion of the inferior turbinate, where there isFigure 3 Normal rhinocytogram: in healthy subjects, the nasal
mucosa is composed of numerous ciliated cells that
characterize the pseudo-stratified epithelium, and few
neutrophils. Staining MGG 1000X.
Figure 4 Immunoflogosis: staining with May-Grunwald-Giemsa
(MGG) method, allows to detect all the cellular components of
the nasal mucosa, including inflammatory cells, such as
neutrophils, eosinophils, lymphocytes and mast cells. Staining
MGG.
Gelardi et al. Italian Journal of Pediatrics 2012, 38:51 Page 3 of 7
http://www.ijponline.net/content/38/1/51an optimal ratio between ciliated and mucous-secreting
cells, usually in favour of ciliated cells. Nevertheless, on a
routine basis, nasal swab is preferred to scraping, since it
is easier and less troublesome, using the latter only when
investigating more collaborative patients. The sampling
step must be carefully performed through anterior rhino-
scopy, using a nasal speculum and good lighting. As
mentioned before, it is a minimally invasive method, so
that local anaesthesia is usually not required.
When the sampling is obtained, the material is placed
on a glass slide, fixed by air drying and stained by May-
Grunwald-Giemsa (MGG) method, which allows the
detection of all the cellular components of the nasal
mucosa, including those cells that are associated to the
immune inflammation process (such as neutrophils,
eosinophils, lymphocytes and mast cells) (Figure 4), and
bacteria, spores and fungi. Staining usually requires
about 30 min; nevertheless, new staining systems are cur-
rently available (MGG QUICK STAIN Bio-Optica, Milan,
Italy), allowing completing such step in less time.
The slide is then observed through a light microscopy
supplied with an object-glass, able to magnify up to
1,000x. For the rhinocytogram analysis, at least 50
microscopic fields have to be read in order to detect
eosinophils, mast cells, neutrophils, bacteria, spores, cal-
culating their percentages and reach a diagnosis [16,17].
Nasal cyto-pathology
Several nasal pathologies have been identified and a large
number of classifications appear in scientific journals,
although a unique classification has not yet been accepted.
In Additional file 1: Table S1 we propose a classification
that aims to be complete and comprehensive, and involves
a heterogeneous range of diseases. From a cellular point
of view, nasal pathologies first affect the ciliated cells,
determining a rearrangement of the epithelium in favour
of mucous-secreting cells (mucous-secreting metaplasia).
This process has important pathophysiological and clinical
consequences, because the increase of mucous-secreting
cells causes a major production of mucous, while the de-
crease in ciliated cells leads to a reduced efficiency of the
muco-ciliated transport. These events favour the stasis of
mucous secretions in the nose, determining a major risk
of bacterial infection [18]. Considering that the turnover
of a ciliated cell takes about three weeks, frequent inflam-
mation does not allow the re-establishment of a normal
ratio between the different cellular subsets [19,20].
Nasal cytology in allergic and non-allergic rhinitis
Patients suffering from seasonal or perennial allergic
rhinitis (AR), when exposed to the causative allergen,
either in the environment or during a nasal provocation
test, develop an immediate nasal response, the so-called
early phase, and then a late phase response [21,22]. Froma microscopic point of view, these responses are charac-
terized by a mucosal infiltration of inflammatory cells
(eosinophils, mast cells, neutrophils and lymphocytes),
which cause the IgE-mediated symptoms (itching, nasal
Figure 5 Perennial allergic rhinitis: if allergen exposure is
persistent throughout the year, a minimal persistent flogosis
may be detected, characterized by a persistent infiltration of
neutrophils and few eosinophils (E). Staining MGG 1000X.
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the different chemical mediators released by such cells.
When the intensity of allergen exposure is low but con-
tinual, as in persistent rhinitis (caused, for example, by
house dust mites allergy), a “minimal persistent inflam-
mation” occurs, characterized by a persistent infiltration
of neutrophils and, only minimally, of eosinophils [23,24]
(Figure 5). Mast cells and degranulating eosinophils are
rarely found. The above-mentioned cellular condition is
clinically translated into a sub-chronic symptomatology,
which characterizes the patients suffering from perennial
AR. Main symptoms include nasal congestion and rhi-
norrhea. As for seasonal AR, the rhinocytogram may beFigure 6 Seasonal allergic rhinitis: nasal cytology in a patient evaluat
presence of numerous neutrophils, lymphocytes, eosinophils and maquite heterogeneous, depending on the period of the year
during which the patient is explored, that is to say during
or outside the pollen season. In fact, during the pollen
season, patients show all the clinical signs of the disease,
and nasal cytology is characterized by the presence of
neutrophils, lymphocytes, eosinophils and mast cells,
mostly degranulating (Figure 6). By contrast, in patients
evaluated outside the pollen season, there are no clinical
or cytological signs that may be detected; this aspect is
even more evident if the pollen season and the allergen
exposure finished more than 30 days before evaluation.
In these cases, for an effective diagnosis, it is mandatory
to perform a nasal provocation test with the specific
allergen or a cytological study during the peak of pol-
lination. A study by our group on patients suffering from
AR showed some striking data: subjects with perennial
rhinitis and mono-sensitized subjects suffering from
pollen-induced AR show different concentrations of
inflammatory cells and nasal resistance measured by
rhinomanometer, if compared with different types of
patients with AR [25]. It is noteworthy that pollen-
induced AR is able to induce higher levels of tissue inflam-
matory cells (eosinophils, neutrophils and mast cells),
and of nasal resistance. Besides the differences in terms
of cellular subsets, as for eosinophils and mast cells, some
modifications have been found in terms of degranulation
level, which varies in accordance with the considered
pollen (grass, parietaria, cypress and olive). Nasal eosino-
philia characterizes allergic diseases at all ages; the pre-
sence of intra- and extra-cellular bacteria is the mark of a
concomitant bacterial infection (allergic rhino-sinusitis).ed during the pollen season; the sample is characterized by the
st cells, partially degranulating. Staining MGG 1000X.
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data) aged 0–13 years, we have been able to detect differ-
ent immunological inflammatory patterns. Moreover,
with such a cohort, we highlighted the existence of non
IgE-mediated rhinopathies in children: non-allergic rhinitis
with eosinophils (NARES, Figure 7A), non-allergic rhinitis
with mast cells (NARMA, Figure 7B), non-allergic
rhinitis with neutrophils (NARNE, Figure 7C), non-allergic
rhinitis with eosinophils and mast cells (NARESMA,
Figure 7D). These cellular rhinopathies present a chronic-
progressive course, more intense symptoms, and induce
local-regional complications (such as rhinosinusitis, and
frequent otitis) and respiratory complications (such as
bronchitis, pneumonia, asthma, rhino-bronchial syn-
drome). If these rhinopathies are not effectively con-
trolled by pharmacotherapy, 20 years later they may
show an evolution towards nasal polyposis [26].
The NARESMA form, a recently described disorder
[8], is the disease with the greatest tendency to develop
complications (nasal polyposis and/or asthma), with the
worst quality of life and severe sleep disturbances (con-
tinuous awakenings, snoring, sleep-apnea syndrome).
“Overlapped” rhinitis
The most important contribute of nasal cytology to
the diagnosis of rhinopathies is the introduction of the
so-called overlap concept; thanks to the cytological
approach, it is actually possible to identify patients
simultaneously suffering from more than one form (for
example AR associated to NARES, NARESMA, etc.).Figure 7 Non IgE-mediated rhinopathies in children: non-allergic rhin
cells (NARMA, B), non-allergic rhinitis with neutrophils (NARNE, C), no
Staining MGG 1000X.The possibility to identify these clinical conditions allows
avoiding a wrong therapeutical approach [27]. Some
patients who present a sensitization to seasonal allergens,
may experience a perennial symptomatology, along with
a positive cytology for eosinophils and mast cells, even
outside the pollen season. In this case, the rhinocytologi-
cal study is very useful tool, since it is able to identify the
concomitance of more diseases in accordance with a dif-
ferential cytological diagnosis.
These clinical conditions are characterized by a more in-
tense vasomotor symptomatology with a chronic course;
if not diagnosed and treated adequately by pharmaco-
logical therapy, often based on personalized cycles of
nasal corticosteroids, and sometimes systemic corticos-
teroids, antihistamines, antileukotrienes, they will show
some sort of complications (such as turbinate dysfunction,
rhino-sinusitis, rhino-bronchial syndrome, rhino-otitis).
The clinical-therapeutic implications of these conditions
are fundamental both for the ENT and the allergy spe-
cialist, but also for paediatricians, since these forms occur
since childhood. If these patients are properly treated by
allergen immunotherapy (AIT), mainly sublingual im-
munotherapy (which is more accepted both by children
and caregivers) [28], they will benefit from the advantages
related to such a treatment (blockage of the so-called
allergic march, and clinical efficacy persisting also after
the end of the immunotherapy course). These patients
must be informed that such a positive outcome occur
only if AIT pre-requisites are fulfilled. In particular,
adequate allergen dosage must be administered for aitis with eosinophils (NARES, A), non-allergic rhinitis with mast
n-allergic rhinitis with eosinophils and mast cells (NARESMA, D).
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patients must be adequately educated in order to ensure
an optimal compliance to the prescribed treatment [30].
Nasal cytology in children
Despite the favourable characteristics of nasal cytology,
only scant data are available on its application in children.
In 1988 Sala et al. showed that children with chronic
rhinitis showed a decrease of the ciliated component and
an increase of goblet cells [31] but no other study was
addressed on the paediatric population. In 2007, the role
of cytology in the diagnosis of rhinosinusitis in children
was reappraised [18], however studies on nasal cytology
in children with rhinitis are still lacking. A recent study
analyzed the histopathology of chronic rhinosinusitis in
children as based on different techniques including nasal
biopsies [32], but it is obvious that nasal biopsies are
hardly feasible as a routine method to detect the inflam-
matory cells in the nose, while cytology has optimal char-
acteristics to assess this aspect.
Conclusions
Taking into account all the above considerations, it is
desirable for nasal cytology to be systematically per-
formed in the diagnostic work-up of nasal disorders in
the paediatric population, in order to reach a better
diagnosis and to set a rational therapeutic approach,
which are fundamental elements to prevent the well-
known complications and to improve the patients’ qua-
lity of life.
Additional file
Additional file 1: Table S1. Classification of rhinopathies.
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